Skip to main content
NCBI home page
Heart logoLink to Heart
. 1997 Mar;77(3):229–233. doi: 10.1136/hrt.77.3.229

A regional study of presentation and outcome of hypertrophic cardiomyopathy in infants.

J R Skinner 1, A Manzoor 1, A M Hayes 1, H S Joffe 1, R P Martin 1
PMCID: PMC484687  PMID: 9093039

Abstract

OBJECTIVE: To describe regional incidence, presentation, and outcome of idiopathic (familial) and Noonan syndrome related infant hypertrophic cardiomyopathy (HCM) between 1969 and 1994. DESIGN: Case series. SETTING: Regional cardiac referral unit of the South West Region of England and south Wales, population approximately four million. PATIENTS: 21 cases of idiopathic (or familial) HCM, and eight infants with Noonan syndrome. MAIN OUTCOME MEASURES: Survival and persistence or resolution of symptoms or cardiac hypertrophy. RESULTS: Incidence: eight cases between 1969 and 1982 (idiopathic 6, Noonan 2), 21 cases between 1982 to 1994 (idiopathic 15, Noonan 6). Mode of presentation: cardiac failure, 17 (59%); murmur, 9 (30%); cyanosis, 2 (7%); family history, 1 (7%). Age at presentation: 0-7 days, 16 (55%); 8 days-4 months, 9 (31%); 5-12 months, 4 (14%). Outcome: five deaths (17%), all < 1 year, all from progressive cardiac failure (idiopathic 3, Noonan 2). Four of these five had not received beta blockade. Among the 24 survivors (follow up 1.3-23.2 years, median 5.5 years) hypertrophy had resolved in nine (38%) (idiopathic 8, Noonan 1), was mild and asymptomatic in seven (29%), and was symptomatic or severe in eight (33%). All 10 infants presenting with septal thickness > 1.3 cm have persistent cardiac hypertrophy. CONCLUSIONS: Mortality in infant HCM is much lower than previously reported and resolution is more frequent. This may reflect increased detection of less severe forms in addition to the success of aggressive medical management including beta blockade.

Full text

PDF
229

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abelmann W. H., Lorell B. H. The challenge of cardiomyopathy. J Am Coll Cardiol. 1989 May;13(6):1219–1239. doi: 10.1016/0735-1097(89)90293-3. [DOI] [PubMed] [Google Scholar]
  2. Burch M. Hypertrophic cardiomyopathy. Arch Dis Child. 1994 Dec;71(6):488–489. doi: 10.1136/adc.71.6.488. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Burch M., Mann J. M., Sharland M., Shinebourne E. A., Patton M. A., McKenna W. J. Myocardial disarray in Noonan syndrome. Br Heart J. 1992 Dec;68(6):586–588. doi: 10.1136/hrt.68.12.586. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Burch M., Sharland M., Shinebourne E., Smith G., Patton M., McKenna W. Cardiologic abnormalities in Noonan syndrome: phenotypic diagnosis and echocardiographic assessment of 118 patients. J Am Coll Cardiol. 1993 Oct;22(4):1189–1192. doi: 10.1016/0735-1097(93)90436-5. [DOI] [PubMed] [Google Scholar]
  5. Carvalho J. S., Matthews E. E., Leonard J. V., Deanfield J. Cardiomyopathy of glycogen storage disease type III. Heart Vessels. 1993;8(3):155–159. doi: 10.1007/BF01744800. [DOI] [PubMed] [Google Scholar]
  6. Davies M. J., McKenna W. J. Hypertrophic cardiomyopathy--pathology and pathogenesis. Histopathology. 1995 Jun;26(6):493–500. doi: 10.1111/j.1365-2559.1995.tb00267.x. [DOI] [PubMed] [Google Scholar]
  7. Hagan A. D., Deely W. J., Sahn D., Friedman W. F. Echocardiographic criteria for normal newborn infants. Circulation. 1973 Dec;48(6):1221–1226. doi: 10.1161/01.cir.48.6.1221. [DOI] [PubMed] [Google Scholar]
  8. Henry W. L., Gardin J. M., Ware J. H. Echocardiographic measurements in normal subjects from infancy to old age. Circulation. 1980 Nov;62(5):1054–1061. doi: 10.1161/01.cir.62.5.1054. [DOI] [PubMed] [Google Scholar]
  9. Landing B. H., Recalde A. L., Lawrence T. Y., Shankle W. R. Cardiomyopathy in childhood and adult life, with emphasis on hypertrophic cardiomyopathy. Pathol Res Pract. 1994 Sep;190(8):737–749. doi: 10.1016/S0344-0338(11)80420-6. [DOI] [PubMed] [Google Scholar]
  10. Manetti A., De Simone L., Pollini I., Favilli S., Scarano E., Donzelli G. P. Transient ventricular septal hypertrophy in the first year of life associated with neonatal brain injury. Pediatr Cardiol. 1992 Jan;13(1):63–64. doi: 10.1007/BF00788235. [DOI] [PubMed] [Google Scholar]
  11. Maron B. J., Cecchi F., McKenna W. J. Risk factors and stratification for sudden cardiac death in patients with hypertrophic cardiomyopathy. Br Heart J. 1994 Dec;72(6 Suppl):S13–S18. doi: 10.1136/hrt.72.6_suppl.s13. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Maron B. J., Tajik A. J., Ruttenberg H. D., Graham T. P., Atwood G. F., Victorica B. E., Lie J. T., Roberts W. C. Hypertrophic cardiomyopathy in infants: clinical features and natural history. Circulation. 1982 Jan;65(1):7–17. doi: 10.1161/01.cir.65.1.7. [DOI] [PubMed] [Google Scholar]
  13. Matsuishi T., Hirata K., Terasawa K., Kato H., Yoshino M., Ohtaki E., Hirose F., Nonaka I., Sugiyama N., Ohta K. Successful carnitine treatment in two siblings having lipid storage myopathy with hypertrophic cardiomyopathy. Neuropediatrics. 1985 Feb;16(1):6–12. doi: 10.1055/s-2008-1052536. [DOI] [PubMed] [Google Scholar]
  14. McKenna W. J., Chetty S., Oakley C. M., Goodwin J. F. Arrhythmia in hypertrophic cardiomyopathy: exercise and 48 hour ambulatory electrocardiographic assessment with and without beta adrenergic blocking therapy. Am J Cardiol. 1980 Jan;45(1):1–5. doi: 10.1016/0002-9149(80)90212-x. [DOI] [PubMed] [Google Scholar]
  15. McKenna W. J., Deanfield J. E. Hypertrophic cardiomyopathy: an important cause of sudden death. Arch Dis Child. 1984 Oct;59(10):971–975. doi: 10.1136/adc.59.10.971. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. McKenna W. J., Oakley C. M., Krikler D. M., Goodwin J. F. Improved survival with amiodarone in patients with hypertrophic cardiomyopathy and ventricular tachycardia. Br Heart J. 1985 Apr;53(4):412–416. doi: 10.1136/hrt.53.4.412. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Obayashi T., Hattori K., Sugiyama S., Tanaka M., Tanaka T., Itoyama S., Deguchi H., Kawamura K., Koga Y., Toshima H. Point mutations in mitochondrial DNA in patients with hypertrophic cardiomyopathy. Am Heart J. 1992 Nov;124(5):1263–1269. doi: 10.1016/0002-8703(92)90410-w. [DOI] [PubMed] [Google Scholar]
  18. Sharland M., Burch M., McKenna W. M., Paton M. A. A clinical study of Noonan syndrome. Arch Dis Child. 1992 Feb;67(2):178–183. doi: 10.1136/adc.67.2.178. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Silver M. M., Silver M. D. Left ventricular hypertrophy versus hypertrophic cardiomyopathy. J Pediatr. 1992 Sep;121(3):500–501. doi: 10.1016/s0022-3476(05)81824-4. [DOI] [PubMed] [Google Scholar]
  20. Spirito P., Chiarella F., Carratino L., Berisso M. Z., Bellotti P., Vecchio C. Clinical course and prognosis of hypertrophic cardiomyopathy in an outpatient population. N Engl J Med. 1989 Mar 23;320(12):749–755. doi: 10.1056/NEJM198903233201201. [DOI] [PubMed] [Google Scholar]
  21. Watkins H. Multiple disease genes cause hypertrophic cardiomyopathy. Br Heart J. 1994 Dec;72(6 Suppl):S4–S9. doi: 10.1136/hrt.72.6_suppl.s4. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Heart are provided here courtesy of BMJ Publishing Group

RESOURCES